小猪视频app

Form: 10QSB

Optional form for quarterly and transition reports of small business issuers

May 15, 1998

Documents

EXHIBIT 11 COMPUTATION OF NET LOSS PER SHARE

Published on May 15, 1998



EXHIBIT 11

CYTOCLONAL PHARMACEUTICS INC.

COMPUTATION OF NET (LOSS) PER COMMON SHARE
(unaudited)


THREE MONTHS THREE MONTHS
ENDED ENDED
MARCH 31, MARCH 31,
1997 1998
------------ ------------

Net (loss) $(738,000) $(790,000)

Add cumulative preferred dividend (78,000) (61,000)
--------- ---------
NET (LOSS) USED FOR COMPUTATION $(816,000) $(851,000)

Weighted average number of common shares
outstanding - basic and diluted loss per share 7,934,000 8,849,000
--------- ---------
Basic and diluted loss per common share $(0.10) $(0.10)